Benchtop NMR urine metabolomics for diagnosing pulmonary tuberculosis
Por:
Comella-del-Barrio, P, Rodríguez, I, Bimba, JS, Osazuwa, O, Alaran, R, Alonso-Moreno, P, Blasco-Iturri, Z, Miguel-Coello, AB, Cuevas, LE, Ruiz-Cabello, J, Izquierdo-Garcia, JL and Domínguez, J
Publicada:
19 nov 2025
Ahead of Print:
19 nov 2025
Resumen:
Tuberculosis (TB) remains a major global health issue, especially in resource-limited settings, where rapid and accurate diagnosis is critical yet often lacking. Nuclear magnetic resonance (NMR)-based metabolomics has emerged as a promising tool for identifying disease-specific biomarkers. This study assessed the diagnostic potential of urinary metabolomics using high-resolution (HR-)NMR and benchtop NMR (bNMR) in Nigerian adults with presumed pulmonary TB, including individuals with and without HIV. Urine samples were analysed by HR-NMR and bNMR. Multivariate analysis was used to develop classification models based on confirmed TB status. Key discriminant metabolites were identified. In HIV-negative individuals, HR-NMR achieved 84% sensitivity and 86% specificity, while bNMR reached 83% and 84%, respectively. In people living with HIV, HR-NMR reached 75% sensitivity and 70% specificity; bNMR achieved 90% and 46%. Both models met or exceeded WHO sensitivity criteria for non-sputum-based TB diagnostics. Thirteen discriminatory metabolites were identified, with eight consistent with previous studies. These findings suggest common metabolic signatures of TB, regardless of HIV status. Urinary NMR-based metabolomics shows strong potential for TB diagnosis in high TB/HIV burden settings. HR-NMR provides excellent accuracy, while bNMR offers a cost-effective alternative. Further studies are needed to validate and optimise this approach for clinical use.
Filiaciones:
Comella-del-Barrio, P:
Inst Invest Germans Trias & Pujol, Barcelona 08916, Spain
Gregorio Maranon Mother & Child Hosp, Paediat Infect Dis Unit, Madrid 28009, Spain
Inst Salud Carlos III, CIBER Enfermedades Infecciosas CIBERINFEC, Madrid 28029, Spain
Rodríguez, I:
Univ Complutense Madrid, Pharm Sch, Dept Chem Pharmaceut Sci, Madrid 28040, Spain
Univ Complutense Madrid, Inst Pluridisciplinar, NMR & Imaging Biomed Grp, Madrid 28040, Spain
Inst Salud Carlos III, CIBER Enfermedades Resp CIBERES, Madrid 28029, Spain
Bimba, JS:
Bingham Univ, Zankli Res Ctr, Karu 961105, Nigeria
Bingham Univ, Dept Community Med, Karu 961105, Nigeria
Osazuwa, O:
Bingham Univ, Zankli Res Ctr, Karu 961105, Nigeria
Bingham Univ, Dept Community Med, Karu 961105, Nigeria
Alaran, R:
Univ Liverpool Liverpool Sch Trop Med, Ctr Drugs & Diagnost, Dept Clin Sci, Liverpool L3 5QA, England
Alonso-Moreno, P:
Univ Complutense Madrid, Pharm Sch, Dept Chem Pharmaceut Sci, Madrid 28040, Spain
Univ Complutense Madrid, Inst Pluridisciplinar, NMR & Imaging Biomed Grp, Madrid 28040, Spain
Blasco-Iturri, Z:
Inst Salud Carlos III, CIBER Enfermedades Resp CIBERES, Madrid 28029, Spain
Basque Res & Technol Alliance BRTA, CIC biomaGUNE, Donostia San Sebastian 20014, Spain
Justus Liebig Univ, Univ Giessen & Marburg Lung Ctr UGMLC, Inst Lung Hlth ILH, German Ctr Lung Res DZL, Giessen, Germany
Justus Liebig Univ, Cardiopulm Inst CPI, Giessen, Germany
Miguel-Coello, AB:
Inst Salud Carlos III, CIBER Enfermedades Resp CIBERES, Madrid 28029, Spain
Basque Res & Technol Alliance BRTA, CIC biomaGUNE, Donostia San Sebastian 20014, Spain
Cuevas, LE:
Univ Liverpool Liverpool Sch Trop Med, Ctr Drugs & Diagnost, Dept Clin Sci, Liverpool L3 5QA, England
Ruiz-Cabello, J:
Univ Complutense Madrid, Pharm Sch, Dept Chem Pharmaceut Sci, Madrid 28040, Spain
Inst Salud Carlos III, CIBER Enfermedades Resp CIBERES, Madrid 28029, Spain
Basque Res & Technol Alliance BRTA, CIC biomaGUNE, Donostia San Sebastian 20014, Spain
Basque Fdn Sci, IKERBASQUE, Bilbao 48009, Spain
Izquierdo-Garcia, JL:
Univ Complutense Madrid, Pharm Sch, Dept Chem Pharmaceut Sci, Madrid 28040, Spain
Univ Complutense Madrid, Inst Pluridisciplinar, NMR & Imaging Biomed Grp, Madrid 28040, Spain
Inst Salud Carlos III, CIBER Enfermedades Resp CIBERES, Madrid 28029, Spain
:
Inst Invest Germans Trias & Pujol, Barcelona 08916, Spain
Inst Salud Carlos III, CIBER Enfermedades Resp CIBERES, Madrid 28029, Spain
Univ Autonoma Barcelona, Biosci Fac, Dept Genet & Microbiol, Barcelona, Spain
Green Submitted, gold
|